DEF 14C: Castellum, Inc. Secures Shareholder Approval for Warrant Issuance in Registered Direct Offering

Castellum, Inc. obtained shareholder consent to issue shares underlying a warrant agreement, facilitating a registered direct public offering.

Summary

• Castellum, Inc. has furnished an information statement to shareholders regarding the approval of a warrant agreement.
• On February 6, 2024, the company received written consent from the Board of Directors and the Audit Committee.
• On February 12, 2024, the company received written consent from holders of over 50.58% of the voting stock.
• The consents relate to the issuance of shares underlying a warrant agreement with an investor.
• The warrant allows the investor to purchase 8,437,501 shares of Common Stock at $0.35 per share, exercisable for five years after shareholder approval.
• The company engaged Maxim Group LLC as the exclusive placement agent for the offering on January 22, 2024.
• The actions will become effective no sooner than twenty calendar days after the information statement is mailed on or about February 27, 2024.

Sentiment

Score: 6

Explanation: The document is neutral in tone, primarily focused on informing shareholders of a corporate action. While the capital raise is a positive, the potential dilution is a concern.

Positives

• The company has successfully secured shareholder approval for the warrant issuance.
• The registered direct offering provides potential capital to the company.
• The warrant agreement has a fixed exercise price of $0.35 per share, which could be beneficial if the stock price increases.
• The company complied with NYSE American LLC rules by obtaining Audit Committee approval.

Negatives

• The issuance of new shares will dilute existing shareholders' ownership.
• The warrant exercise price of $0.35 may be lower than the current market price, potentially undervaluing the shares.
• The company is relying on a registered direct offering, which may indicate difficulty in securing capital through other means.

Risks

• The company's stock price may be negatively impacted by the dilution caused by the warrant exercise.
• The investor may choose not to exercise the warrant if the stock price does not reach a certain level.
• The company's reliance on a single placement agent (Maxim Group LLC) could limit its access to potential investors.
• Forward-looking statements involve substantial risks and uncertainties, and actual results may differ materially.

Future Outlook

The company anticipates the warrant agreement will become effective no sooner than 20 calendar days after the information statement is mailed to shareholders.

Management Comments

• Mark C. Fuller, Chief Executive Officer, urges shareholders to read the Information Statement in its entirety.

Industry Context

Registered direct offerings are a common method for small-cap companies to raise capital quickly, often with the assistance of a placement agent.

Comparison to Industry Standards

• The terms of the warrant agreement, such as the exercise price and duration, are typical for similar financing transactions in the small-cap market.
• Comparable companies in the government contracting sector, such as CACI International and Booz Allen Hamilton, typically rely on a mix of debt and equity financing, but not usually registered direct offerings.

Stakeholder Impact

• Shareholders will experience dilution of their ownership if the warrant is exercised.
• The company may benefit from the capital raised through the offering.
• The investor will have the opportunity to purchase shares at a fixed price.

Next Steps

• The company will mail the Information Statement to shareholders on or about February 27, 2024.
• The warrant agreement will become effective no sooner than 20 calendar days after the mailing date.
• The investor may then exercise the warrant to purchase shares of Common Stock.

Key Dates

Keywords

Warrant Agreement, Shareholder Approval, Registered Direct Offering, Common Stock, Castellum, Maxim Group LLC, Securities Purchase Agreement